NCT01685073View on ClinicalTrials.gov

The Role of Sleep in the Treatment of Cannabis Use Disorders

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Drug Addiction

Interventions

DRUG

Zolpidem extended-release

nightly administration of zolpidem extended-release

BEHAVIORAL

MET/CBT

a standardized 12-week therapy consisting of motivational enhancement therapy (MET) and cognitive behavior therapy (CBT) for treating cannabis use disorders will be administered to all study participants

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT01685073 - The Role of Sleep in the Treatment of Cannabis Use Disorders | Biotech Hunter | Biotech Hunter